Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2025-12-25 @ 3:31 AM
NCT ID:
NCT05103605
Eligibility Criteria:
Inclusion Criteria:
* Descriptive cross-sectional survey (Population B)
* Adult patients (≥ 18 years old),
* Patients newly treated in first line (1L) for locally advanced or metastatic NSCLC,
* Patients with activating EGFR mutation-positive,
* Patient informed and not opposed to these data collection.
* Prospective cohort (Population A)
* Patient meeting part B inclusion criteria,
* Patients newly treated in 1L by osimertinib,
* Patient with common EGFR mutation-positive (exon 19 deletion or L858R mutation, alone or co-occuring with other EGFR mutations).
Exclusion Criteria (Population A):
* Patients enrolled in interventional clinical trials (first line treatment for a NSCLC) during the study period.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05103605
Study Brief:
Protocol Section:
NCT05103605